Artennua is an optimized version of Artemisia annua – a medicinal plant used for centuries in Chinese Medicine and is the source of artemisinin, the molecule recommended by the WHO to treat malaria. Artemisinin, its derivatives, and other secondary metabolites have the potential to treat many other afflictions; however, Artemisia annua produces very low quantities of artemisinin and thus global supply is limited. At Sequentia we are scientists and social entrepreneurs; we have used natural plant biopharming methods to improve the characteristics of the Artemisia annua plant so that its benefits can be exploited.
The newspaper interviews our CEO of Biotech Tricopharming Research Luis Matias, who explains how our Artennua product works and what growth and development prospects we expect. Luis also focuses on the strategic importance of Canary Islands for Artennua production. Indeed, Artennua could become an important crop for the region given its valuable and international trade…
We are delighted to share with you our new flyer showing Artennua potential on Animal Health.Plants are very important for animal health. As within the human population, incidence of chronic disorders are growing in both companion pets and livestock...
Today, on World Entrepreneur Day, we received an amazing news: we are winners of the 23th Canary Islands Entrepreneurship Award by FYDE. The CajaCanaria Bank Foundation supporting the entrepreneurship (Fundación Canaria para la Formación y Desarrollo Empresarial de CajaCanarias) selected the finalists from different islands. The jury was composed by the General Director of the…
